POM Investment Strategies’s Cellectis CLLS Stock Holding History

POM Investment Strategies’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49K	Hold	495	–	–	﹤0.01%	318
2026 Q1	$1.57K	Hold	495	–	–	﹤0.01%	388
2025 Q4	$2.4K	Hold	495	–	–	﹤0.01%	274
2025 Q3	$1.41K	Hold	495	–	–	﹤0.01%	173
2025 Q2	$755	Hold	495	–	–	﹤0.01%	126
2025 Q1	$614	Hold	495	–	–	﹤0.01%	193
2024 Q4	$891	Hold	495	–	–	﹤0.01%	306
2024 Q3	$1.05K	Hold	495	–	–	﹤0.01%	255
2024 Q2	$926	Hold	495	–	–	﹤0.01%	296
2024 Q1	$1.31K	Hold	495	–	–	﹤0.01%	216
2023 Q4	$1.52K	Buy	+495	New	+$1.18K	﹤0.01%	196

Other funds holding CLLS

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

POM Investment Strategies's CLLS Position: Q2 2026 in Review

POM Investment Strategies held its Cellectis (CLLS) position steady in Q2 2026 at 495 shares worth $1.49K. The position accounts for ﹤0.01% of the portfolio, ranked #318.

POM Investment Strategies first reported a position in CLLS in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.4K in Q4 2025. 3 funds tracked by Wall St. Rank hold CLLS as of Q2 2026.

POM Investment Strategies held 495 shares of Cellectis worth $1.49K as of Q2 2026.
POM Investment Strategies left its Cellectis share count unchanged in Q2 2026.
Cellectis made up ﹤0.01% of POM Investment Strategies's portfolio in Q2 2026, its #318 holding.
POM Investment Strategies first reported a position in Cellectis in Q4 2023 and has held it in 11 quarters since.
POM Investment Strategies's Cellectis position peaked at $2.4K in Q4 2025.
3 funds tracked by Wall St. Rank held Cellectis as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.